课题基金 / 基金详情

项目摘要

项目成果

Kitai Kim的其他基金

相似基金

相关文献

中文摘要
翻译
项目概述(见说明):
英文摘要
PROJECT SUMMARY (See instructions): The goal of this research is to create histocompatible patient specific hematopoietic stem cells, which in addition to their potential therapeutic value, will provide novel tools for in-depth study of reprogramming and differentiation. The Specific Aims of this proposal are: Specific Aims 1: Generation of histocompatible mmctES cells using microcell mediated chromosome transfer (mmct) in mouse. Specific Aim 2: Testing of hematopoietic potential in mmctES cells by in vitro and in vivo methods. The limited availability of human oocytes required for both nuclear transferred (nt) ES and parthenogenetic (p) ES cell techniques poses a significant obstacle to generating customized embryonic stem cells. Therefore, alternative methods to generate similar types of cells are needed. Generation of ES cells by oocyte free methods already has been demonstrated by fusion of somatic cells (sc) and embryonic stem (es) cells to reprogram the somatic cells. However, removal of the genetic material from the resultant tetraploid sc-es hybrid ES cells to make diploid ES cells has not been achieved. As an alternative approach, I propose microcell-mediated transfer to ES cells of mouse sc-chromosome 17 and human sc-chromosome 6, which contain the major histocompatibility complex (MHC). The resultant duplicated mouse es-chromosome 17 and human sc-chromosome 6 will then be removed to make diploid mmctES cells in mouse
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A new hypothesis: role of p53 inhibitory factors in cellular reprogramming
A new hypothesis: role of p53 inhibitory factors in cellular reprogramming
A new hypothesis: role of p53 inhibitory factors in cellular reprogramming
Hematopoietic potential of histocompatible embryonic stem cell lines
  • 批准号:
    7510675
  • 项目类别:
  • 资助金额:
    $8.94万
  • 财政年份:
    2008
  • 负责人:
    Kitai Kim
  • 依托单位:
海外基金